Specialists of the domestic pharmaceutical company Farmak have developed and brought to market a drug for the treatment of acute (stroke) and chronic cerebrovascular disorders: Lira (citicoline). The new drug is produced in the form of a solution for injection in 1000 mg ampoules No. 5 and 500 mg ampoules No. 5.
Farmak is actively working in the sphere of treatment of cardiovascular diseases. In particular, much attention is given to ensure comprehensive effective and affordable treatment of acute and chronic cerebrovascular disorders. To achieve this objective, the company's specialists have developed and brought to market the drug product Lira (citicoline).
Lira is indicated in the acute phase of cerebrovascular disorders and for the treatment of cerebrovascular complications and sequelae; in craniocerebral traumas and their consequences, neurological disorders (cognitive, sensitive and motor) caused by degenerative and vascular cerebral disorders.
The course of treatment with the drug is 4-6 weeks.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...